Lewis JS - Search Results

1

Intra-tumoral distribution of (64)Cu-ATSM: a comparison study with FDG.

Obata A, Yoshimoto M, Kasamatsu S, Naiki H, Takamatsu S, Kashikura K, Furukawa T, Lewis JS, Welch MJ, Saji H, Yonekura Y, Fujibayashi Y. Obata A, et al. Among authors: lewis js. Nucl Med Biol. 2003 Jul;30(5):529-34. doi: 10.1016/s0969-8051(03)00047-7. Nucl Med Biol. 2003. PMID: 12831991

2

Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.

Lewis JS, McCarthy DW, McCarthy TJ, Fujibayashi Y, Welch MJ. Lewis JS, et al. J Nucl Med. 1999 Jan;40(1):177-83. J Nucl Med. 1999. PMID: 9935074 Free article.

3

High purity production and potential applications of copper-60 and copper-61.

McCarthy DW, Bass LA, Cutler PD, Shefer RE, Klinkowstein RE, Herrero P, Lewis JS, Cutler CS, Anderson CJ, Welch MJ. McCarthy DW, et al. Among authors: lewis js. Nucl Med Biol. 1999 May;26(4):351-8. doi: 10.1016/s0969-8051(98)00113-9. Nucl Med Biol. 1999. PMID: 10382836

4

Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): An agent for radiotherapy.

Lewis J, Laforest R, Buettner T, Song S, Fujibayashi Y, Connett J, Welch M. Lewis J, et al. Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1206-11. doi: 10.1073/pnas.98.3.1206. Proc Natl Acad Sci U S A. 2001. PMID: 11158618 Free PMC article.

5

A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.

Chao KS, Bosch WR, Mutic S, Lewis JS, Dehdashti F, Mintun MA, Dempsey JF, Perez CA, Purdy JA, Welch MJ. Chao KS, et al. Among authors: lewis js. Int J Radiat Oncol Biol Phys. 2001 Mar 15;49(4):1171-82. doi: 10.1016/s0360-3016(00)01433-4. Int J Radiat Oncol Biol Phys. 2001. PMID: 11240261

6

Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation.

Lewis JS, Sharp TL, Laforest R, Fujibayashi Y, Welch MJ. Lewis JS, et al. J Nucl Med. 2001 Apr;42(4):655-61. J Nucl Med. 2001. PMID: 11337556 Free article.

7

PET imaging of hypoxia.

Lewis JS, Welch MJ. Lewis JS, et al. Q J Nucl Med. 2001 Jun;45(2):183-8. Q J Nucl Med. 2001. PMID: 11476169 Review.

8

Copper-64-pyruvaldehyde-bis(N(4)-methylthiosemicarbazone) for the prevention of tumor growth at wound sites following laparoscopic surgery: monitoring therapy response with microPET and magnetic resonance imaging.

Lewis JS, Connett JM, Garbow JR, Buettner TL, Fujibayashi Y, Fleshman JW, Welch MJ. Lewis JS, et al. Cancer Res. 2002 Jan 15;62(2):445-9. Cancer Res. 2002. PMID: 11809694

9

Retention mechanism of hypoxia selective nuclear imaging/radiotherapeutic agent cu-diacetyl-bis(N4-methylthiosemicarbazone) (Cu-ATSM) in tumor cells.

Obata A, Yoshimi E, Waki A, Lewis JS, Oyama N, Welch MJ, Saji H, Yonekura Y, Fujibayashi Y. Obata A, et al. Among authors: lewis js. Ann Nucl Med. 2001 Dec;15(6):499-504. doi: 10.1007/BF02988502. Ann Nucl Med. 2001. PMID: 11831397

10

Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships.

Dearling JL, Lewis JS, Mullen GE, Welch MJ, Blower PJ. Dearling JL, et al. Among authors: lewis js. J Biol Inorg Chem. 2002 Mar;7(3):249-59. doi: 10.1007/s007750100291. Epub 2001 Sep 8. J Biol Inorg Chem. 2002. PMID: 11935349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,018 results

Search Page

Filters